These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9303739)

  • 1. [Comparative evaluation of the anti-arrhythmia effect of KLN-93, dicaine, and lidocaine during neurogenic atrial fibrillation].
    Leonidov NB; Galenko-Iaroshevskiĭ PA; Sheĭkh-Zade IuR; Cherednik IL; Fitilev SB; Galygo DS; Khankoeva AI
    Biull Eksp Biol Med; 1997 Jul; 124(7):77-80. PubMed ID: 9303739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of the anti-arrhythmia efficacy of fencarol and dimebon during neurogenic atrial fibrillation].
    Galenko Iaroshevskiĭ PA; Cherednik IL; Bartashevich VV; Sheĭkh-Zade IuR; Khankoeva AI
    Biull Eksp Biol Med; 1997 Jul; 124(7):81-5. PubMed ID: 9303740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of zyline in atrial fibrillation in humans].
    Comşulea L; Luca C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(4):315-20. PubMed ID: 43566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of KLN-93 on ventricular fibrillation induced by reperfusion or electrical stimulation in cats].
    Leonidov NB; Galenko-Iaroshevskiĭ PA; Fitilev SB; Kniazhev VA; Gatsura VV
    Biull Eksp Biol Med; 1997 Aug; 124(8):135-7. PubMed ID: 9410191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the mechanisms of the anti-arrhythmic action of marcaine and lidocaine].
    Kaverina NV; Darinskiĭ NV; Berdiaev SIu; Dzhaparidze MM
    Farmakol Toksikol; 1984; 47(3):46-50. PubMed ID: 6734807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local anesthetics and their quaternary derivatives as anti-arrhythmia agents].
    Gendenshteĭn EI; Tsybusov AP
    Farmakol Toksikol; 1985; 48(1):112-7. PubMed ID: 2579846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of antiarrhythmic effects of methacizine and its components during neurogenic atrial fibrillation].
    Cherednik IL; Sheikh-Zade IuR; Galenko-Iaroshevskiĭ PA; Stodolia GA
    Biull Eksp Biol Med; 1999 Sep; 128(9):291-3. PubMed ID: 10560048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative anti-arrhythmia activity of rinocaine and lidocaine].
    Galenko-Iaroshevskiĭ PA; Sheikh-Zade IuR; Reznikov AIu; Onopriev VV; Khankoeva AI; Gumeniuk SE; Pavlenko SG
    Biull Eksp Biol Med; 1996 Nov; 122(11):517-20. PubMed ID: 8998340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in the medicamentous defibrillation of the heart].
    Körber H; Frank HH; Timm T
    Z Arztl Fortbild (Jena); 1977 Oct; 71(19):897-900. PubMed ID: 595643
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.
    Dobrev D; Nattel S
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):293-9. PubMed ID: 18791467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors for successful conversion of atrial fibrillation using intravenous injection of pilsicainide hydrochloride].
    Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Matsumoto K; Yamakawa Y; Ohkusu Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Aug; 42(2):81-6. PubMed ID: 12964518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of neurotropic component in therapeutic effect of the anti-arrhythmia agents].
    Sheikh-Zade IuR; Cherednik IL; Galenko-Iaroshevskiĭ PA
    Biull Eksp Biol Med; 1999 Mar; 127(3):353-6. PubMed ID: 10225121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].
    Niakara A; Nébié LV; Samadoulougou AK; Kaboré NJ; Ouandaogo BJ; Drabo YJ
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):113-7; discussion 118. PubMed ID: 12555335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New onset of atrial fibrillation--rate or rhythm control?].
    Lewalter T
    MMW Fortschr Med; 2009 Apr; 151(16):29, 31-2. PubMed ID: 19658292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of anti-arrhythmic effect of allapinin during neurogenic atrial fibrillation].
    Cherednik IL; Sheikh-Zade IuP; Galenko-Iaroshevskiĭ PA
    Biull Eksp Biol Med; 1999 Feb; 127(2):174-6. PubMed ID: 10095948
    [No Abstract]   [Full Text] [Related]  

  • 17. [Paroxysmal atrial fibrillation: which patients need anti-arrhythmia drugs?. Interview by Dr. med. Ulrike Hennemann].
    Meinertz T
    Fortschr Med; 1996 Aug; 114(24):42-3. PubMed ID: 8974971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative pharmacologic characteristics of various anticonvulsant, anti-arrhythmic and local anesthetic compounds].
    Motovilov PE
    Farmakol Toksikol; 1972; 35(5):581-3. PubMed ID: 4652008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardioprotective effects of the cyclic derivative of gamma-aminobutyric acid T3-146 during reperfusion].
    Galenko-Iaroshevskiĭ PA; Kryzhanovskiĭ SA; Uvarov AV; Turovaia AIu; Popov PB; Khankoeva AI
    Biull Eksp Biol Med; 1997 Nov; 124(11):533-6. PubMed ID: 9471249
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.